147 related articles for article (PubMed ID: 7572551)
1. 'Dose dumping' and sustained-release theophylline.
Welch JS
Am Fam Physician; 1995 Oct; 52(5):1278, 1284. PubMed ID: 7572551
[No Abstract] [Full Text] [Related]
2. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
3. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
5. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
Jones DT; Sears MR
N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
[TBL] [Abstract][Full Text] [Related]
6. [The clinical application of long-acting preparations of theophylline].
Tanaka K
Nihon Rinsho; 1996 Nov; 54(11):3108-12. PubMed ID: 8950963
[TBL] [Abstract][Full Text] [Related]
7. [Slow-release theophylline for the treatment of asthmatic children].
Iwasaki E; Baba M
Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
[TBL] [Abstract][Full Text] [Related]
8. Theophylline controlled-release formulations: in vivo-in vitro correlations.
Yu Z; Schwartz JB; Sugita ET
Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
[TBL] [Abstract][Full Text] [Related]
9. Theophylline clearance in undernourished asthma patients.
Raj NS; Misra A; Guleria R; Pande JN
Indian J Chest Dis Allied Sci; 1998; 40(3):175-8. PubMed ID: 9919837
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
11. Effect of gallbladder contraction induced cholagogia on the pharmacokinetic profile of a sustained-release theophylline formulation.
Fuchs WS; von Nieciecki A; Molz KH; Popescu G; Weil A; Barkworth MF; Gay S; Laicher A; Stanislaus F
Arzneimittelforschung; 1996 Dec; 46(12):1120-6. PubMed ID: 9006785
[TBL] [Abstract][Full Text] [Related]
12. [Serum concentrations of the pyridoxal and pyridoxal-5'-phosphate in children during sustained-release theophylline therapy].
Tanaka I; Ito Y; Hiraga Y; Fujino M; Kobayashi K
Arerugi; 1996 Oct; 45(10):1098-105. PubMed ID: 8958656
[TBL] [Abstract][Full Text] [Related]
13. [Bronchodilator: theophylline].
Nishihara K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():414-8. PubMed ID: 15658352
[No Abstract] [Full Text] [Related]
14. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
[No Abstract] [Full Text] [Related]
15. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics].
Kotake T; Mihara M; Shibakawa M; Asamoto
Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals.
Welsh PW; O'Connell EJ; Sachs MI; Moyer TP; Wick KA; Harrison LI; McCarville SE; Kvam DC
Ann Allergy; 1989 May; 62(5):396-400. PubMed ID: 2719348
[TBL] [Abstract][Full Text] [Related]
17. Oral fenoterol versus sustained release theophylline in adult asthmatics.
Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
20. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]